Immunomic Therapeutics' Series B Round

Immunomic Therapeutics raised a round of funding on October 17, 2013.

Immunomic Therapeutics (ITI) is a clinical stage biotechnology company developing vaccines based on LAMP Technology. The company's LAMP-vax platform increases the effectiveness of the immune response …

Articles about Immunomic Therapeutics' Series B Round: